Korean J Radiol.  2019 May;20(5):695-708. 10.3348/kjr.2018.0774.

Use of Cardiac Computed Tomography and Magnetic Resonance Imaging in Case Management of Atrial Fibrillation with Catheter Ablation

• Lee HG
• Shim J
• Choi JI
• Kim YH
• Oh YW
• Hwang SH

• KMID: 2442704
• DOI: http://doi.org/10.3348/kjr.2018.0774

Abstract

Atrial fibrillation (AF) is the most common arrhythmia associated with the risk of morbidity and mortality in clinical patients. AF is considered as an arrhythmia type that develops and progresses through close connection with cardiac structural arrhythmogenic substrates. Since the introduction of catheter ablation-mediated electrical isolation of arrhythmogenic substrates, cardiac imaging indicates improved treatment outcome and prognosis with appropriate candidate selection, ablation catheter guidance, and post-ablation follow-up. Currently, cardiac computed tomography (CCT) and cardiovascular magnetic resonance (CMR) imaging are essential in the case management of AF at both pre-and post-procedural stages of catheter ablation. In this review, we discuss the roles and technical considerations of CCT and CMR imaging in the management of patients with AF undergoing catheter ablation.

Keyword

Computed tomography; Magnetic resonance imaging; Arrhythmia; Atrial fibrillation; Catheter ablation

MeSH Terms

Arrhythmias, Cardiac
Atrial Fibrillation*
Case Management*
Catheter Ablation*
Catheters*
Follow-Up Studies
Humans
Magnetic Resonance Imaging*
Mortality
Prognosis
Treatment Outcome

Figure

• 

  Fig. 1 Function of LA during normal sinus rhythm and during AF.In normal sinus rhythm, LA function consists of 1) LA reservoir function at LV systole, 2) LA conduit function during early LV diastole, and 3) LA pump function at late LV diastole. In contrast to sinus rhythm, AF results in rapid and inconsistent heart motion, which may be associated with blurring heart contours on cardiac images. AF = atrial fibrillation, LA = left atrium, LV = left ventricle

• 

  Fig. 2 Evaluation of LA volume by 3D techniques of CMR imaging.Transverse (A) and coronal (B) reformatting of CMR images helps determination of LA chamber areas. Sum of LA chamber areas (green) on thin slice CMR images (C) can be considered as measurement of actual LA volume. PVs and LAA are usually excluded in LA volume measurement using 3D LA model. CMR = cardiovascular magnetic resonance, LAA = left atrial appendage, LSPV = left superior pulmonary vein, PVs = pulmonary veins, RIPV = right inferior pulmonary vein, RSPV = right superior pulmonary vein, 3D = three-dimensional

• 

  Fig. 3 LA fibrosis determined with 3D LGE-CMR imaging.3D LGE-CMR image (A) with excellent spatial resolution describes thin LA wall and hyperenhancement areas (arrows) in detail. Segmentation of thin LA wall with slice thickness of < 2 mm (B, C) can reconstruct 3D LA models (D–F) which show tissue composition of LA wall in basis of signal intensity of LGE (arrows, yellow foci). LGE = late-gadolinium enhancement, LIPV = left inferior pulmonary vein

• 

  Fig. 4 Evaluation of LAA function by CMR imaging.VENC CMR imaging can quantify blood flow through LAA ostium. Mechanically, active emptying of LAA can be represented mechanically by active contraction of LAA. It can be measured by peak blood flux (in mL/s) which develop at LV late diastole in sinus rhythm. VENC = velocity-encoded

• 

  Fig. 5 LV myocardial remodeling by CMR imaging in patient with AF.Recent CMR technique provides assessment of myocardial ECV in LV wall derived from pre- and post-contrast T1 maps in patients with AF. In 40-year-old man with persistent AF, ECV map shows mean LV myocardial ECV of 31.69%. Usually, it has been widely accepted that mean LV myocardial ECV is less than 28% in healthy individuals without definite cardiomyopathy. ECV = extracellular volume fraction

• 

  Fig. 6 PV anatomy and LA by CCT images.Isotropic voxel data from CCT scan can be reformatted into transverse (A) and coronal (B) multiplanar images. 3D volume rendering image (C) of CCT reveals stereoscopic view inside LA chamber and PV ostium. In 3D volume rendering images of PVs, typical anatomy comprises four PVs with separate ostia (D). Atypical PV anatomy mainly comprises common ostia for left PVs (arrow) (E) and additional right middle PV (arrow) (F). CCT = cardiac computed tomography

• 

  Fig. 7 Evaluation of PV by CMR imaging.TR-MRA shows sequential contrast enhancement of large vessels from PA (A), through LA and aorta (B), to IVC (C). Multi-phase images by TR-MRA allows reconstruction of 3D models including CS, IVC, right atrium and LA. CS = coronary sinus, IVC = inferior vena cava, PA = pulmonary artery, TR-MRA = time-resolved magnetic resonance angiography

• 

  Fig. 8 Electroanatomic mapping.Electroanatomic maps can help guide catheters (arrow) (A), reveal process of ablation lines (B), and fuse between LA model from cardiac image data and shell of electrophysiologic study (C) during catheter ablation of AF.

• 

  Fig. 9 Ablation-induced LA scar by 3D LGE-CMR imaging.Post-procedural 3D LGE-CMR image shows thick LA wall areas of bright signal intensity (arrowheads) due to ablation-induced LA scar near RSPV. Post-procedural 3D LA model by LGE reveals ablation lines (arrowheads) surrounding LA antrum for electrical isolation of RSPV.

• 

  Fig. 10 Enlargement of LAA after catheter ablation of AF.Post-procedural 3D LGE-CMR image shows thick LA wall areas of bright signal intensity (arrows) due to ablation-induced LA scar near ostium of LAA. Compared with pre-procedural CMR images, dimension of LAA ostium (red box) was decreased although chamber of LAA was enlarged. Volume of LAA increased from 49.6–61.7 mL after catheter ablation of AF.

• 

  Fig. 11 PV stenosis in 50-year-old male who underwent catheter ablation of AF.Transverse chest CT image (A) shows interstitial edema and consolidation of left lung lower lobe. Chest CT image (B) with mediastinal window set shows interstitial edema and luminal narrowing of LIPV (arrow). Conventional angiography (C) also shows focal narrowing of LIPV as PV stenosis (arrow). Six-month follow-up cardiac CT image (D) shows in-stent restenosis (arrow) after stent insertion for PV stenosis.

• 

  Fig. 12 Atrioesophageal fistula in 43-year-old male who underwent catheter ablation of AF.Electroanatomic map (A) shows multiple ablation points forming antrum ablation line (arrow) for electrical isolation of LSPV just anterior to Eso (arrowhead). Transverse chest CT image (B) shows small air-bubble (arrow) near LSPV. Sagittal reformatting image of chest CT (C) shows air-bubbles (arrow) between ESo (arrowhead) and LA. Fluid-attenuated inversion recovery magnetic resonance image of brain (D) reveals embolic stroke with multiple foci of bright signal intensity in bilateral cerebral hemispheres. Eso = esophagus

Reference

1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64:e1–e76. PMID: 24685669.

2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37:2893–2962. PMID: 27567408.

3. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108:3006–3010. PMID: 14623805.

4. Nattel S, Allessie M, Haissaguerre M. Spotlight on atrial fibrillation-the ‘complete arrhythmia’. Cardiovasc Res. 2002; 54:197–203. PMID: 12062326.

5. Ehrlich JR, Cha TJ, Zhang L, Chartier D, Melnyk P, Hohnloser SH, et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol. 2003; 551:801–813. PMID: 12847206.

6. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012; 9:632–696. e621PMID: 22386883.

7. Haïssaguerre M, Gencel L, Fischer B, Le Métayer P, Poquet F, Marcus FI, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1994; 5:1045–1052. PMID: 7697206.

8. Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol. 2009; 104:366–372. PMID: 19616669.

9. Bhagirath P, van der Graaf AW, Karim R, van Driel VJ, Ramanna H, Rhode KS, et al. Multimodality imaging for patient evaluation and guidance of catheter ablation for atrial fibrillation - current status and future perspective. Int J Cardiol. 2014; 175:400–408. PMID: 25012494.

10. Njeim M, Desjardins B, Bogun F. Multimodality Imaging for guiding EP ablation procedures. JACC Cardiovasc Imaging. 2016; 9:873–886. PMID: 27388666.

11. Cabrera JA, Sánchez-Quintana D. Cardiac anatomy: what the electrophysiologist needs to know. Heart. 2013; 99:417–431. PMID: 23355600.

12. Mahnkopf C, Badger TJ, Burgon NS, Daccarett M, Haslam TS, Badger CT, et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm. 2010; 7:1475–1481. PMID: 20601148.

13. Cha YM, Wokhlu A, Asirvatham SJ, Shen WK, Friedman PA, Munger TM, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011; 4:724–732. PMID: 21747059.

14. Bisbal F, Guiu E, Calvo N, Marin D, Berruezo A, Arbelo E, et al. Left atrial sphericity: a new method to assess atrial remodeling. Impact on the outcome of atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2013; 24:752–759. PMID: 23489827.

15. Bax JJ, Marsan NA, Delgado V. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation. Heart. 2015; 101:94–100. PMID: 25412729.

16. Delgado V, Di Biase L, Leung M, Romero J, Tops LF, Casadei B, et al. Structure and function of the left atrium and left atrial appendage: AF and stroke implications. J Am Coll Cardiol. 2017; 70:3157–3172. PMID: 29268928.

17. Maceira AM, Cosín-Sales J, Roughton M, Prasad SK, Pennell DJ. Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2010; 12:65. PMID: 21070636.

18. Kistler PM, Sanders P, Fynn SP, Stevenson IH, Spence SJ, Vohra JK, et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004; 44:109–116. PMID: 15234418.

19. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014; 311:498–506. PMID: 24496537.

20. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009; 119:1758–1767. PMID: 19307477.

21. McGann CJ, Kholmovski EG, Oakes RS, Blauer JJ, Daccarett M, Segerson N, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008; 52:1263–1271. PMID: 18926331.

22. Naksuk N, Padmanabhan D, Yogeswaran V, Asirvatham SJ. Left atrial appendage: embryology, anatomy, physiology, arrhythmia and therapeutic intervention. JACC Clin Electrophysiol. 2016; 2:403–412. PMID: 29759858.

23. Wazni O, Wilkoff B, Saliba W. Catheter ablation for atrial fibrillation. N Engl J Med. 2011; 365:2296–2304. PMID: 22168644.

24. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med. 1995; 123:817–822. PMID: 7486462.

25. Patel A, Au E, Donegan K, Kim RJ, Lin FY, Stein KM, et al. Multidetector row computed tomography for identification of left atrial appendage filling defects in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation: comparison with transesophageal echocardiography. Heart Rhythm. 2008; 5:253–260. PMID: 18242550.

26. Lotz J, Meier C, Leppert A, Galanski M. Cardiovascular flow measurement with phase-contrast MR imaging: basic facts and implementation. Radiographics. 2002; 22:651–671. PMID: 12006694.

27. Hwang SH, Oh YW, Kim MN, Park SM, Shim WJ, Shim J, et al. Relationship between left atrial appendage emptying and left atrial function using cardiac magnetic resonance in patients with atrial fibrillation: comparison with transesophageal echocardiography. Int J Cardiovasc Imaging. 2016; 32(Suppl 1):163–171. PMID: 27119163.

28. Hwang SH, Roh SY, Shim J, Choi JI, Kim YH, Oh YW. Atrial fibrillation: relationship between left atrial pressure and left atrial appendage emptying determined with velocity-encoded cardiac MR imaging. Radiology. 2017; 284:381–389. PMID: 28394753.

29. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med. 1998; 158:1316–1320. PMID: 9645825.

30. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A, et al. Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace. 2013; 15:1540–1556. PMID: 23981824.

31. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, et al. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project. Eur J Heart Fail. 2012; 14:295–301. PMID: 22294759.

32. Allessie MA, de Groot NM, Houben RP, Schotten U, Boersma E, Smeets JL, et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation. Circ Arrhythm Electrophysiol. 2010; 3:606–615. PMID: 20719881.

33. Sibley CT. Characterization of ventricular myocardium in atrial fibrillation: looking where the light is best. JACC Cardiovasc Imaging. 2014; 7:12–13. PMID: 24433706.

34. Addison D, Farhad H, Shah RV, Mayrhofer T, Abbasi SA, John RM, et al. Effect of late gadolinium enhancement on the recovery of left ventricular systolic function after pulmonary vein isolation. J Am Heart Assoc. 2016; 5:pii: e003570.

35. Suksaranjit P, Akoum N, Kholmovski EG, Stoddard GJ, Chang L, Damal K, et al. Incidental LV LGE on CMR imaging in atrial fibrillation predicts recurrence after ablation therapy. JACC Cardiovasc Imaging. 2015; 8:793–800. PMID: 26093929.

36. Avitall B, Bi J, Mykytsey A, Chicos A. Atrial and ventricular fibrosis induced by atrial fibrillation: evidence to support early rhythm control. Heart Rhythm. 2008; 5:839–845. PMID: 18534368.

37. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008; 52:1574–1580. PMID: 19007595.

38. Neilan TG, Mongeon FP, Shah RV, Coelho-Filho O, Abbasi SA, Dodson JA, et al. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. JACC Cardiovasc Imaging. 2014; 7:1–11. PMID: 24290570.

39. Wagner M, Butler C, Rief M, Beling M, Durmus T, Huppertz A, et al. Comparison of non-gated vs. electrocardiogram-gated 64-detector-row computed tomography for integrated electroanatomic mapping in patients undergoing pulmonary vein isolation. Europace. 2010; 12:1090–1097. PMID: 20525729.

40. Blackham KA, Passalacqua MA, Sandhu GS, Gilkeson RC, Griswold MA, Gulani V. Applications of time-resolved MR angiography. AJR Am J Roentgenol. 2011; 196:W613–W620. PMID: 21512053.

41. Kim JS, Oh YW, Shim J, Kim YH, Hwang SH. Optimal cardiac magnetic resonance contrast-enhanced timing robust angiography (CMR-CENTRA) for the three-dimensional reconstruction of the bilateral atria in the electroanatomic mapping (EAM) of atrial fibrillation. Investig Magn Reson Imaging. 2017; 21:131–138.

42. Caponi D, Corleto A, Scaglione M, Blandino A, Biasco L, Cristoforetti Y, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010; 12:1098–1104. PMID: 20400766.

43. Tsuchiya T. Three-dimensional mapping of cardiac arrhythmias - string of pearls. Circ J. 2012; 76:572–581. PMID: 22327031.

44. Sra J, Narayan G, Krum D, Malloy A, Cooley R, Bhatia A, et al. Computed tomography-fluoroscopy image integration-guided catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007; 18:409–414. PMID: 17284262.

45. Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, et al. Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology. 2007; 243:690–695. PMID: 17517928.

46. Ranjan R, Kato R, Zviman MM, Dickfeld TM, Roguin A, Berger RD, et al. Gaps in the ablation line as a potential cause of recovery from electrical isolation and their visualization using MRI. Circ Arrhythm Electrophysiol. 2011; 4:279–286. PMID: 21493875.

47. Badger TJ, Daccarett M, Akoum NW, Adjei-Poku YA, Burgon NS, Haslam TS, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol. 2010; 3:249–259. PMID: 20335558.

48. Kurotobi T, Iwakura K, Inoue K, Kimura R, Toyoshima Y, Ito N, et al. The significance of the shape of the left atrial roof as a novel index for determining the electrophysiological and structural characteristics in patients with atrial fibrillation. Europace. 2011; 13:803–808. PMID: 21398655.

49. Lee JM, Kim JB, Uhm JS, Pak HN, Lee MH, Joung B. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA₂DS₂-VASc scores. Heart Rhythm. 2017; 14:1297–1301. PMID: 28559088.

50. Kim YG, Shim J, Oh SK, Park HS, Lee KN, Hwang SH, et al. Different responses of left atrium and left atrial appendage to radiofrequency catheter ablation of atrial fibrillation: a follow up MRI study. Sci Rep. 2018; 8:7871. PMID: 29777140.

51. Chang SH, Tsao HM, Wu MH, Tai CT, Chang SL, Wongcharoen W, et al. Morphological changes of the left atrial appendage after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007; 18:47–52. PMID: 17096656.

52. Holmes DR Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009; 2:267–276. PMID: 19463436.

53. Fender EA, Widmer RJ, Hodge DO, Cooper GM, Monahan KH, Peterson LA, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation. 2016; 134:1812–1821. PMID: 27793993.

54. Greenway SC, Yoo SJ, Baliulis G, Caldarone C, Coles J, Grosse-Wortmann L. Assessment of pulmonary veins after atrio-pericardial anastomosis by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2011; 13:72. PMID: 22104689.

55. Prieto LR, Kawai Y, Worley SE. Total pulmonary vein occlusion complicating pulmonary vein isolation: diagnosis and treatment. Heart Rhythm. 2010; 7:1233–1239. PMID: 20206715.

56. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3:32–38. PMID: 19995881.

57. Pollak SJ, Monir G, Chernoby MS, Elenberger CD. Novel imaging techniques of the esophagus enhancing safety of left atrial ablation. J Cardiovasc Electrophysiol. 2005; 16:244–248. PMID: 15817079.